Do you want to read an article? Please log in or register.
Neighborhood-level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung Disease
Interstitial Lung DiseasePulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Fibrotic interstitial lung diseases and air pollution: a systematic literature review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir Rev.
Harari S, Raghu G, Caminati A, Cruciani M, Franchini M, Mannucci P
doi: 10.1183/16000617.0093-2020.
RECOMMENDED
Pulmonary FibrosisRespiratory Tract InfectionFurther Publications
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
Lancet Respir Med.
Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA
doi: 10.1016/
RECOMMENDED
Interstitial Lung Disease
Impact of Lung Biopsy Information on Treatment Strategy of Patients with Interstitial Lung Diseases
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Ann Am Thorac Soc
Tomassetti S, Ravaglia C, Puglisi S, Ryu JH, Colby TV, Cavazza A, Wells AU, Pavone M, Vancheri C, Lavorini F, Matucci-Cerinic M, Rosi E, Luzzi V, Gori L, Rossi G, Donati L, Dubini A, Piciucchi S, Poletti V
doi: 10.1513/AnnalsATS.202104-466OC
RECOMMENDED
Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study
Respir Res.
Guler SA, Hur SA, Lear SA, Camp PG, Ryerson CJ
doi: 10.1186/s12931-
RECOMMENDED
Interstitial Lung Disease
Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease - a randomised placebo-controlled trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Kronborg-White S, Andersen CU, Kohberg C, Hilberg O, Bendstrup E
doi: 10.1186/s12931-020-01452-7.
Interstitial Lung Disease
Functional aging in fibrotic interstitial lung disease: The impact of frailty on adverse health outcomes
Eur Respir J.
Guler SA, Kwan JM, Leung JM, Khalil N, Wilcox PG, Ryerson CJ
doi: 10.1183/13993003.00647-2019.
RECOMMENDED
Interstitial Lung Disease
Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med.
Krauss E, El-Guelai M, Pons-Kuehnemann J, Dartsch RC, Tello S, Korfei M, Mahavadi P, Breithecker A, Fink L, Stoehr M, Majeed RW, Seeger W, Crestani B, Guenther A
doi: 10.3390/jcm9082499.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M, INBUILD trial investigators.
doi: 10.1016/S2213-2600(20)30036-9.
RECOMMENDED
Interstitial Lung Disease
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Eur Respir J.
Jacob J, Hirani N, van Moorsel CHM, Rajagopalan S, Murchison JT, van Es HW, Bartholmai BJ, van Beek FT, Struik MHL, Stewart GA, Kokosi M, Egashira R, Brun AL, Cross G, Barnett J, Devaraj A, Margaritopoulos G, Karwoski R, Renzoni E, Maher TM, Wells AU
doi: 10.1183/13993003.00869-2018.